EC
PHVS icon

Elmind Capital’s Pharvaris PHVS Stock Holding History

Elmind Capital’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2M Buy
525,750
+50,000
+11% +$1.51M 4.57% 7
2026
Q1 		$13.4M Hold
475,750
– – 3.82% 9
2025
Q4 		$13.2M Buy
+475,750
New +$11.5M 3.9% 10

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Elmind Capital's PHVS Position: Q2 2026 in Review

Elmind Capital increased its Pharvaris (PHVS) stake by 11% in Q2 2026, buying an estimated $1.51M and bringing the position to 525,750 shares worth $18.2M. The position accounts for 4.57% of the portfolio, ranked #7.

Elmind Capital first reported a position in PHVS in Q4 2025 and has held it in 3 quarters since. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Elmind Capital held 525,750 shares of Pharvaris worth $18.2M as of Q2 2026.
  • Elmind Capital bought 50,000 Pharvaris shares in Q2 2026, an estimated $1.51M.
  • Pharvaris made up 4.57% of Elmind Capital's portfolio in Q2 2026, its #7 holding.
  • Elmind Capital first reported a position in Pharvaris in Q4 2025 and has held it in 3 quarters since.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Elmind Capital's 13F filing for Q2 2026, filed 14 Aug 2026.